Imaging showed a statistically significant increase in the tumor binding potential of [11C]-AnxA5-ST after doxorubicin, which was even larger if compared to [11C]-mTrx-GFP-ST (Fig. 2D). This evidence concerns the gene ANXA5 and neoplasm.